To test whether AT2‑derived lipids are required for metastasis, the researchers selectively deleted Fasn in AT2 cells.

The model has the potential to transform the ability to study telomere biology, learn more about human aging, and ultimately help people preserve better health as they age.

A new strategy strengthens the bond between the T cell and a target tumor cell, improving the cytotoxic function of the T cell.

Researchers say discovery could establish the basis for a novel, tandem biomarker-peptide therapeutic approach to schizophrenia.

Nautilus debuted its platform at the US HUPO meeting last month and is seeking additional participants for its ongoing early access program.

The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a large DNA payload into T cells in vivo.

Roche’s AI factories, protein design reasoning model, and healthcare robotics are among GTC announcements for biology.

Cayman advanced the protocol from a 1-L setup to a 100-L pilot run, operating the reaction and analysis independently.

Construction is already underway at Axplora's Farmabios HPAPI manufacuring facility in Italy, with completion targeted for February 2027.

Astellas Pharma has ended a six-year-old collaboration with CytomX Therapeutics designed to both expand the pharma giant’s pipeline of next-gen immuno-oncology treatments and generate up to $1.68 ...

The team, from biopharmaceutical company Regeneron, hopes their work will help researchers better understand protein-protein interactions during preclinical development of a drug. “Essentially, we ...

AI automation, and more skilled staff are needed to ensure cancer patients can access potentially life-saving CAR T therapies.